Anticancer researchHumansCarcinomaHepatocellularLiver NeoplasmsMale
Prior Radiotherapy Improves Progression-free Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Tremelimumab-Durvalumab.
Akifumi Kuwano, Kosuke Tanaka, Taikan Hamamoto, Kazuki Kurosaka, Hideo Suzuki, Masayoshi Yada, Yoshihiro Ohishi, Tomonari Sasaki, Kenta Motomura
Published: 202510.21873/anticanres.17903
Abstract
BACKGROUND/AIM: Recent advances in systemic therapies, including immune checkpoint inhibitors (ICIs), have improved outcomes for patients with advanced hepatocellular carcinoma (HCC). Radiotherapy and ICI therapy have been reported to have synergisti…
Preview only. Read the full abstract at the source